Gastric Sleeve For Diabetes: How the Surgery Permanently Cures Type 2 Diabetes

Op. Dr. Volkan Arayıcı

Specialist in Bariatric & Metabolic Surgery · Izmir, Turkey

✓ IFSO Member  |  ✓ 5,000+ Operations  |  ✓ Specialist since 2014

This article was written and medically reviewed by Op. Dr. Volkan Arayıcı. Dr. Arayıcı has been exclusively specialised in bariatric surgery since 2014 and has performed over 5,000 procedures in a JCI-accredited clinic in Izmir.

Gastric Sleeve For Diabetes

In my daily practice, I experience something that many patients can barely believe when they first hear it: Type 2 diabetes that has been treated with tablets or insulin for years disappears completely in many cases after a gastric sleeve operation. Not improved – but gone. No more medication. Normal blood sugar. Healthy HbA1c values.

This effect of the gastric sleeve for diabetes is scientifically well-documented and visible in my own practice every day. As a bariatric surgeon with over a decade of experience, I have witnessed this transformation in hundreds of patients. In this article, I explain why this is the case, who it applies to – and what you can realistically expect.

Can Gastric Sleeve Cure Diabetes? What the Data Shows

The answer is: yes, in a significant proportion of cases. Bariatric medicine speaks of “remission” – a term that means diabetes is clinically no longer detectable, without requiring medication.

The remission rates after gastric sleeve surgery for Type 2 diabetes are impressive:

•  of patients achieve complete remission within 12 months of the procedure.60 to 70 percent
•  show significant improvement – they require less medication and have better blood sugar values, even if complete remission does not occur.A further 15 to 20 percent
• In patients who have had diabetes for less than five years at the time of surgery and have no insulin dependency, remission rates rise to over 80 percent.

The gastric sleeve diabetes remission is well documented in medical literature – more than 1,000 studies have investigated this phenomenon since the 1990s. What was once considered a side effect of weight loss is now recognised as an independent metabolic therapy.

These numbers speak clearly. And they explain why many endocrinologists and diabetologists today no longer view bariatric surgery as a last resort, but as a fully valid treatment option that should be discussed early.

For comparison: even the most effective diabetes medications lower HbA1c by an average of 1 to 2 percentage points. Gastric sleeve surgery for diabetes can bring it into the normal range – permanently.

Why Gastric Sleeve Works on Diabetes – The Mechanism

Most of my patients ask this question: “Why does the diabetes disappear? Because I lose weight?” The answer is: not only. The effect of gastric sleeve surgery on blood sugar is more complex – and in one important respect, even independent of weight loss.

Hormonal Effect: More GLP-1, Less Ghrelin

The gastric sleeve removes approximately 75 to 80 percent of the stomach, including the so-called fundus – the area where the hunger hormone ghrelin is produced. After the procedure, ghrelin levels drop significantly. This means: less hunger, more stable blood sugar curves, reduced insulin requirement.

At the same time, the intestinal passage changes. Food reaches the small intestine more quickly, which increases the secretion of GLP-1 (glucagon-like peptide-1). GLP-1 is an intestinal hormone that stimulates insulin secretion, inhibits glucagon release, and enhances the feeling of satiety. Ozempic and similar medications try to pharmacologically replicate exactly this effect – the gastric sleeve produces it physiologically and permanently.

The Metabolic Effect Begins Earlier Than Weight Loss

This is the point that comes as the greatest surprise for many of my patients. As early as the first seven to ten days after surgery – long before significant weight loss has occurred – blood sugar normalises measurably in many diabetic patients.

This proves that weight loss alone is not the only explanation. The hormonal changes caused by the altered stomach and faster intestinal passage act directly on glucose metabolism. This early metabolic effect is a strong argument for bariatric surgery as an independent diabetes treatment – and not merely as a consequence of weight loss.

Insulin Resistance Permanently Overcome

Type 2 diabetes is based on two core problems: insulin resistance of the body cells and declining insulin production by the pancreas. The gastric sleeve addresses both aspects.

The drastic weight loss – my patients lose an average of 60 to 70 percent of their excess weight within 12 to 18 months – reduces visceral fat mass, which is primarily responsible for insulin resistance. As abdominal fat decreases, body cells can once again respond sensitively to insulin, and the pancreas recovers measurably in many cases. A system that has been working against itself for years begins to function again.

Which Diabetic Patients Benefit Most from Gastric Sleeve?

Not every patient with Type 2 diabetes benefits equally from gastric sleeve surgery. In my clinical practice, I have observed clear patterns that align with the scientific literature.

Duration of Diabetes

The shorter the diabetes history, the higher the probability of remission. Patients who have had Type 2 diabetes for less than five years show remission rates of over 80 percent in studies. With a disease duration of more than ten years, this rate decreases – the beta cells of the pancreas have then often suffered permanent damage and cannot fully regenerate even after the procedure.

This does not mean that patients with long-standing diabetes do not benefit. They too achieve significant improvements in many cases, considerably reduce their medications, and improve their long-term prognosis. But expectations must be set realistically.

HbA1c Value and Medication Status

An HbA1c below 8 percent at the time of surgery is associated with better remission outcomes. Patients treated exclusively with oral antidiabetics respond better to the procedure than insulin-dependent patients – although significant improvements are also possible with insulin.

An important note: insulin dependence is not an exclusion criterion for bariatric surgery. It merely means that the remission expectation should be set somewhat lower and aftercare must be particularly carefully planned.

BMI and Accompanying Conditions

Standard guidelines recommend bariatric surgery for diabetes Type 2 from a BMI of 35. The IDF (International Diabetes Federation) and an increasing number of specialist societies, however, advocate for intervention from BMI 30, when diabetes and other comorbidities are present and conservative therapies have not responded adequately.

In my practice, I discuss each case individually. BMI thresholds are reference points, not absolute rules. What matters is the overall picture: diabetes control, comorbidities, treatment history, and the patient’s willingness to consistently live the postoperative lifestyle.

Gastric Sleeve or Gastric Bypass for Diabetes – Which Is Better?

This question comes up regularly in my consultations. And it has no universal answer.

Gastric bypass produces a stronger hormonal effect because the stomach contents completely bypass the upper small intestine (duodenum and proximal jejunum). This change in intestinal passage stimulates GLP-1 secretion even more strongly than with gastric sleeve. Remission rates are 80 to 90 percent – significantly higher.

Why then do I not generally recommend gastric bypass for diabetes? Because it is technically more complex and has a different long-term complication profile. Nutritional deficiencies – vitamin B12, iron, calcium – are more common after bypass and require lifelong structured supplementation. The anatomical change is also considerably more extensive and irreversible.

My clinical decision logic:

Situation	Tendency
Diabetes duration under 8 years, HbA1c under 9%, no insulin dependency	Gastric Sleeve
Long-standing, poorly controlled diabetes, high insulin doses	Gastric Bypass
Patient prefers less invasive procedure	Gastric Sleeve
Maximum probability of remission desired	Gastric Bypass

This table is a guide, not an algorithm. We make the decision together – after detailed discussion, laboratory results, and physical examination.

Gastric Sleeve or Ozempic? What Really Helps in the Long Term

In recent years, a new question has entered my consultations: “I’m already taking Ozempic – why should I still have surgery?”

GLP-1 agonists like Ozempic (semaglutide) or Mounjaro (tirzepatide) are effective medications. They lower blood sugar, promote weight loss, and reduce cardiovascular risks. That is undisputed. But there are crucial differences from bariatric surgery:

Permanence: The effect of Ozempic only lasts as long as the medication is taken. Studies show that after discontinuation, a significant portion of the lost weight returns – and with it, the diabetes. The gastric sleeve permanently changes the physiology.

Depth of effect: In patients with established Type 2 diabetes and BMI over 35, bariatric surgery shows higher remission rates than GLP-1 medications in long-term comparisons.

Costs and availability: Long-term therapy with GLP-1 agonists is expensive – and in many countries, often not covered by health insurance. A one-time surgery – especially at a specialised clinic – can be the more cost-effective solution in the long run.

Synergy effect: An interesting observation from recent studies: patients who have taken GLP-1 agonists before bariatric surgery show better postoperative outcomes in some cases, because insulin resistance has already been reduced beforehand.

My recommendation is not “either or.” It is an individual assessment. For patients with BMI over 35 and Type 2 diabetes, bariatric surgery is currently the most effective long-term therapy according to current knowledge.

The First Weeks After Gastric Sleeve: What Happens to Blood Sugar

For insulin-dependent patients, the first period after gastric sleeve surgery is a phase that requires careful medical supervision. Blood sugar values improve quickly – and this harbours a risk that is often underestimated: hypoglycaemia.

When a patient who has been injecting insulin daily barely eats after surgery and insulin resistance simultaneously decreases, the usual insulin dose can lead to dangerous hypoglycaemia. Therefore, insulin-dependent patients are closely monitored after surgery and the dose is gradually reduced or discontinued.

Typical progression in my patients:

• First measurable improvement in fasting blood sugar values, often visible while still in hospital.Days 1–7: 
• Stepwise reduction or discontinuation of oral antidiabetics. With insulin: significant dose reduction under close monitoring.Weeks 2–8: 
• HbA1c check shows first reliable results. Many patients are already medication-free at this point.Months 3–6: 
• With complete remission: HbA1c below 6.5 percent, no medication needed.Month 12: 

After discharge, I recommend regular blood glucose self-monitoring for at least the first six months for my diabetic patients – even if they feel well. The improvements can occur rapidly and must be closely documented so that medication can be adjusted in time.

Important: Diabetics planning gastric sleeve surgery should choose a clinic with experience in interdisciplinary diabetes care. Coordination between surgeon, diabetologist, and nutritional counselling is crucial during this phase.

Gastric Sleeve for Diabetes in Turkey – What to Expect

Diabetes surgery in Turkey is a well-considered decision for many patients – not only for economic reasons, but because specialised bariatric centres in Turkey bring years of experience with diabetic patients. Costs are significantly below European levels, while quality at specialised clinics is fully comparable.

Whoever plans diabetes surgery in Turkey should bring all relevant values to the initial consultation: HbA1c, fasting blood sugar, kidney function, and a complete medication list.

What I give my diabetes patients before the procedure:

Come with complete laboratory values: HbA1c, fasting blood sugar, kidney function (creatinine, eGFR), lipids, liver values. If you take insulin, communicate this clearly in the first consultation – dose adjustment and monitoring must be planned from the start, not just at admission.

In hospital: Our team closely monitors blood sugar and initiates an adjusted medication strategy immediately after surgery. Insulin-dependent patients receive a protocol specifically tailored to them.

Aftercare: Diabetics need regular HbA1c checks after gastric sleeve – initially every three months. Even after complete remission, I recommend annual checks. Should weight increase in the long term, blood sugar values may rise again. Early detection is key here.

The costs of gastric sleeve surgery at my clinic in Izmir are calculated all-inclusive – surgery, anaesthesia, hospital stay, accommodation, and transfers. No hidden additional costs.

My Experiences as a Bariatric Surgeon

I have been performing gastric sleeve operations for over a decade. A significant proportion of my patients come with Type 2 diabetes – and the changes I observe in the months after the procedure are among the most impressive moments of my professional life.

One patient, 52 years old, diabetic for nine years, insulin-dependent for three years, HbA1c of 8.8 percent at admission. Six months after gastric sleeve: HbA1c 5.9 percent, no insulin, no oral antidiabetics. She had not thought it possible.

This case is not an isolated one. But it is also not a guarantee – and I communicate this clearly before every surgery. What I can promise: thorough preoperative evaluation, a technically precise procedure, and structured aftercare specifically tailored to diabetic patients.

Frequently Asked Questions

© Op. Dr. Volkan Arayıcı · volkanarayici.com · WhatsApp: +90 532 466 67 67